An Exploratory Study to Describe Virological Effect, Safety, and Pharmacokinetics of VIR-7831 Monoclonal Antibody in Hospitalized Participants With COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is an exploratory study in which hospitalized participants with COVID-19 will receive VIR-7831 (GSK4182136) or matching placebo with assessments of virological effect, safety and pharmacokinetics (PK). The study will be comprised of two phases: The Lead-in phase and the Expansion phase.
Epistemonikos ID: 97c9777836404ea926dcff6b6bd44542d3ad3451
First added on: Feb 24, 2021